Condition: Heavy Menstrual Bleeding · Abnormal Uterine Bleeding · Menorrhagia · Sponsor: Channel Medsystems
Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress registry, to gather data during real world utilization of the Cerene® Cryotherapy Device (Cerene). The primary objective of this registry is to bridge the gap between clinical results and outcomes achieved and reported during the pivotal study of Cerene and those obtained during its real-world use.
This description comes directly from the study's public registry record.
Gerard Reilly, MD · 513-231-3447 · gpreilly.shcrg@gmail.com
Brigette L. Tillman, RN · 513-231-3447 · btillman.shcrg@gmail.com
Always discuss trial participation with your own doctor first.
| Axia Women's Health / Rubino OB/GYN Group | West Orange, New Jersey, United States | Completed |
| Seven Hills Women's Health Centers | Cincinnati, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05922657